Free Trial

Annovis Bio (ANVS) SEC Filings & 10K Form

Annovis Bio logo
$2.79 +0.11 (+3.99%)
Closing price 03:59 PM Eastern
Extended Trading
$2.74 -0.04 (-1.51%)
As of 06:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Annovis Bio SEC Filings

DateFilerForm TypeView
06/23/2025
4:25 PM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2025
5:01 AM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2025
5:00 AM
Annovis Bio (Issuer)
Maccecchini Maria-Luisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
3:36 PM
Annovis Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2025
3:41 PM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2025
11:06 AM
Annovis Bio (Subject)
CVI Investments, Inc. (Filed by)
Form SCHEDULE 13G/A
05/01/2025
4:20 PM
Annovis Bio (Filer)
Form DEFA14A
05/01/2025
4:20 PM
Annovis Bio (Filer)
Form ARS
04/30/2025
4:20 PM
Annovis Bio (Filer)
Form DEF 14A
03/27/2025
3:35 PM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
4:15 PM
Annovis Bio (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/21/2025
4:10 PM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
10:07 AM
Annovis Bio (Subject)
CVI Investments, Inc. (Filed by)
Form SCHEDULE 13G
02/05/2025
7:08 AM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
5:01 AM
Annovis Bio (Filer)
Form 424B5
02/03/2025
5:00 AM
Annovis Bio (Filer)
Form 424B5
12/11/2024
3:25 PM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
5:07 AM
Annovis Bio (Filer)
Form 424B5
12/11/2024
5:10 AM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
4:08 PM
Annovis Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/15/2024
7:12 AM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
7:38 AM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
6:15 AM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2024
7:05 AM
Annovis Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:ANVS) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners